Navigation Links
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
Date:7/23/2009

to discuss these results (see conference call details below).

"Our objective with R788 in RA is to position the product after methotrexate and before biological therapies are used. We have shown excellent results in that patient population in our earlier TASKi1 and TASKi2 studies, and we believe that patient population represents the large market opportunity for this product," said James M. Gower, chairman and chief executive officer of Rigel. "In this TASKi3 patient population, biologic failures, we have seen divergent results as sometimes happens in studies with subjective components. However, we are pleased to see excellent results in the objective measures and in the Synovitis and Osteitis MRI scores," he added.

*blood measurements of C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR)

    Efficacy Results

    Treatment  N of Pts     ACR 20       ACR 50       ACR 70     DAS28<2.6
    ---------  --------     ------       ------       ------     ---------
    Placebo          73     27 (37%)      9 (12%)       4 (6%)      6 (10%)
    -------         ---     -------       ------        -----       ------
    100 mg bid      146     56 (38%)     32 (22%)      13 (9%)     15 (12%)
                             p=0.84       p=0.09       p=0.37       p=0.15
    ----------      --- ------------ ------------ ------------  -----------

    p=values compared to placebo
    Note: At 3 months. All patients were on stable doses of methotrexate
          throughout the clinical trial.



    MRI Results

    TASKi3 Mean Change from Baseline in RAMRIS* Scores at Month 3

                  Placebo      100 mg bid         p=values
                  -------      ----------         --------
    Synovitis**     +0.35            -0.52         p=0.038
    ----------      -----            -----         -------
    Osteitis**
     Score          +1.17            -0.19        
'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 The western European automated endoscope ... largely a replacement market with fewer new installations ... and partnerships are redefining competitive landscape in western ... provides details about revenue forecasts, unit shipments, market ... the country. The changing landscape makes it important ...
(Date:9/22/2014)... , September 22, 2014 ... http://www.researchandmarkets.com/research/8ndtrc/freeze_drying_ ) has announced the addition of ... (Lab, Pilot, & Industrial) Market - Forecast ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,The global freeze ... in 2014 and is expected to reach ...
(Date:9/22/2014)... September 22, 2014 Final ... 25   The second edition of the ... excited to announce the final nominations for the 2014 ... on the evening of September 25 at The Taj Mahal Palace, ... applicants based on a variety of qualitative and quantitative ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3
...  SuccessEHS announces that its newest release will increase physician ... to previous releases.  The company has optimized features and ... and Practice Management software solution to make ... will focus on user efficiency and physician productivity ...
...  Snow tires? Check! Anti-freeze? Check! Window scraper? Check! Gloves? ... to prepare your skin for the effects of winter. ... skin that is rough, flaky, and downright unsightly. This ... it starts with AmLactin® Moisturizing Body Lotion. Wrap yourself ...
Cached Medicine Technology:Newest SuccessEHS Release to Increase Physician Software Usability 2Newest SuccessEHS Release to Increase Physician Software Usability 3Don't Let Your Skin Take a Backseat As You Prepare for Winter 2Don't Let Your Skin Take a Backseat As You Prepare for Winter 3
(Date:9/22/2014)... On Saturday, September 27, UHY LLP and UHY Cares ... is doing an amazing job helping kids and refurbishing school ... and friends will be spending the day at Academy of ... graphics, as well as clean the playground and surrounding park ... in May but due to weather conditions it was postponed ...
(Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- Teens and young ... "intensive" behavioral counseling to help prevent risky sexual behaviors, ... Task Force. Every year, about 20 million new ... in the United States. About half involve people between ... force. Its new report, published Sept. 22 ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
Breaking Medicine News(10 mins):Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2
... Updated Information Provided to Customers , LANDOVER, Md., Jan. ... to pull products containing peanut butter and peanut paste ... has traced the salmonella to a plant owned by ... recalled products from our shelves including:, ...
... The association between tobacco smoke and cancer deaths ... by a recent study from a UC Davis researcher, ... lives than previously estimated. , The epidemiological analysis, published ... more than 70 percent of the cancer death burden ...
... /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... CEO. Terry is the current President and CEO of Shenzhen ... , a company targeted for a merger with HTDS. (See ... filings on Pink Sheets shortly. , Mr. Terry Yuan will ...
... to 50 million uninsuredsteeply rising insurance premiumsemployers cutting ... picture. In Disease, Diagnoses, and Dollars: Facing the ... Robert Kaplan takes America,s healthcare industry to task ... in it. , Provocative, timely, and comprehensively researched, ...
... MIAMI, Jan. 21 Financial services leader ING and the ... contest that,celebrates their success in the ING Run For Something ... The top three essays were submitted by ... Dade Middle School, 7th grade, -- Christian ...
... Favorite Body Parts: Our Faces are Fabulous; Tummies ... abs top the list of favorite and least favorite ... to a new survey conducted by American Laser Centers, ... U.S.Nearly a quarter of the men (24 percent) and ...
Cached Medicine News:Health News:Giant Food Responds to Recall of Peanut Based Products 2Health News:UC Davis study links smoking with most male cancer deaths 2Health News:Hard To Treat Diseases (HTDS) To Name New CEO and Directors 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 3Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 4Health News:How Does Our Vanity Fare? 2
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Minimal M9CA Broth...
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
...
Medicine Products: